New hope for cancer patients suffering devastating drug side effect
NCT ID NCT04305145
Summary
This study tests whether the drug infliximab works better than standard steroid treatment to control severe colon inflammation (colitis) caused by cancer immunotherapy drugs. The trial involves 42 adults with advanced skin cancer who developed this serious side effect while receiving immunotherapy. Researchers want to see which treatment helps patients achieve symptom relief without needing ongoing steroids after 7 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.